ADARx Pharmaceuticals Expands Leadership Team, Appointing Christopher Prentiss as CFO
SAN DIEGO–(BUSINESS WIRE)–ADARx Pharmaceuticals, a biotechnology company developing RNA-targeting therapeutics, today announced the expansion of their leadership team through the appointment of Christopher Prentiss as Chief Financial “I am delighted to welcome Chris to ADARx with his extensive…
Read More